Clinical Trial: A Study in Healthy Men to Test Whether Carbamazepine Influences the Amount of Verducatib in the Blood

U.S., Aug. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07781631) titled 'A Study in Healthy Men to Test Whether Carbamazepine Influences the Amount of Verducatib in the Blood' on Aug. 20.

Brief Summary: The main objective of this trial is to investigate the effect of carbamazepine, a strong CYP3A4 inducer on the pharmacokinetics of verducatib at steady state.

Study Start Date: Sept. 10

Study Type: INTERVENTIONAL

Condition: Healthy

Intervention: DRUG: Verducatib

Verducatib

DRUG: Carbamazepine

Carbamazepine

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Boehringer Ingelheim

Disclaimer: Curated by HT Syndication....